Skip to main content
Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.4400
-0.0300 (-6.38%)
Mar 28, 2025, 3:57 PM EST

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had revenue of $14.36M in the quarter ending December 31, 2024, a decrease of -7.56%. This brings the company's revenue in the last twelve months to $70.00M, up 47.93% year-over-year. In the fiscal year ending March 31, 2024, Elite Pharmaceuticals had annual revenue of $56.63M with 65.79% growth.

Revenue (ttm)
70.00M
Revenue Growth
+47.93%
P/S Ratio
7.09
Revenue / Employee
1.09M
Employees
64
Market Cap
502.09M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202456.63M22.47M65.79%
Mar 31, 202334.16M1.89M5.87%
Mar 31, 202232.26M6.88M27.11%
Mar 31, 202125.38M7.39M41.05%
Mar 31, 202017.99M10.43M137.76%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
SS Innovations International 16.04M
Veradigm 588.02M
Glass House Brands 200.90M
Northwest Biotherapeutics 1.60M
American Oncology Network 1.59B
Silence Therapeutics 43.26M
BioStem Technologies 210.49M
Revenue Rankings

Elite Pharmaceuticals News

More News